Secondary prevention of osteoporotic fractures: Why not apply the evidence?

Serge Ferrari

doi:10.4414/smw.2008.12460

Viewpoint

Vol. 138 No. 4546 (2008)

Secondary prevention of osteoporotic fractures: Why not apply the evidence?

Serge Ferrari

Fulltext PDF

DOI: https://doi.org/10.4414/smw.2008.12460
Cite this as:: Swiss Med Wkly. 2008;138:656-657
Published: 15.11.2008

How to Cite

1.

Ferrari S. Secondary prevention of osteoporotic fractures: Why not apply the evidence?. Swiss Med Wkly [Internet]. 2008 Nov. 15 [cited 2024 Oct. 10];138(4546):656-7. Available from: https://smw.ch/index.php/smw/article/view/913

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Serge Ferrari, Kurt Lippuner, Olivier Lamy, Christian Meier, 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) , Swiss Medical Weekly: Vol. 150 No. 3940 (2020)
Christian Meier, Brigitte Uebelhart, Bérengère Aubry-Rozier, Martin Birkhäuser, Heike A. Bischoff-Ferrari, Diana Frey, Reto W. Kressig, Olivier Lamy, Kurt Lippuner, Petra Stute, Norbert Suhm, Serge Ferrari, Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO) , Swiss Medical Weekly: Vol. 147 No. 3334 (2017)
Christian Meier, Olivier Lamy, Marc-Antoine Krieg, Hans-Ulrich Mellinghoff, Markus Felder, Serge Ferrari, René Rizzoli, The role of teriparatide in sequential and combination therapy of osteoporosis , Swiss Medical Weekly: Vol. 144 No. 2324 (2014)
Serge Ferrari, Christian Meier, Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) , Swiss Medical Weekly: Vol. 153 No. 4 (2023)